Detalhe da pesquisa
1.
Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network.
Haematologica
; 104(12): 2358-2360, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439675
2.
Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers.
Genome Res
; 25(4): 478-87, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25644835
3.
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.
Lancet Oncol
; 17(8): 1127-1136, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402145
4.
Characterization of freshly isolated bone marrow mesenchymal stromal cells from healthy donors and patients with multiple myeloma: transcriptional modulation of the microenvironment.
Haematologica
; 105(9): e470-473, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054066
5.
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
Lancet Oncol
; 15(12): e538-48, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25439696
6.
Induction therapy for newly diagnosed multiple myeloma.
J Natl Compr Canc Netw
; 11(1): 19-28, 2013 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23307978
7.
Current challenges in the management of patients with relapsed/refractory multiple myeloma.
Oncology (Williston Park)
; 25 Suppl 2: 10-8, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25188478
8.
Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response.
Leuk Res
; 33(1): 170-3, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18722011
9.
Correction: Early myeloma-related death in elderly patients: development of a clinical prognostic score and evaluation of response sustainability role.
Leukemia
; 33(4): 1056, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30846864
10.
CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Clin Cancer Res
; 10(22): 7599-606, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15569991
11.
FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor.
Hematol J
; 5(3): 239-46, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15167911
12.
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
Clin Cancer Res
; 20(15): 4014-25, 2014 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24833663
13.
Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.
Cytometry B Clin Cytom
; 78(4): 239-52, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20155853
14.
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.
Blood
; 102(3): 1108-13, 2003 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12649159